https://www.optimumcomms.com/wp-content/uploads/2026/10/ionctura-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-15 08:38:022026-10-15 08:38:32iOnctura appoints Paul Sekhri as Chair of its Board of Directors
https://www.optimumcomms.com/wp-content/uploads/2026/07/Mission_Therapeutics_Logo_300x180px-80x80Web_Logos-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-15 08:32:102026-10-16 09:53:35Mission Therapeutics doses first Parkinson’s patient in Phase 1b study of potential disease-modifying treatment MTX325
https://www.optimumcomms.com/wp-content/uploads/2025/09/DaltonTx.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-15 08:30:562026-10-15 08:31:05DaltonTx awarded grant to accelerate AI-powered tuberculosis drug discovery
https://www.optimumcomms.com/wp-content/uploads/2026/10/Template_Logo_300x180px-80x80Web_Logos-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-14 08:36:592026-10-14 08:36:59Sapreme Therapeutics announces oral presentation of new preclinical data on lead Duchenne muscular dystrophy candidate SPM-2551 at OTS 2026
https://www.optimumcomms.com/wp-content/uploads/2025/09/Hansa-Biopharma.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-13 11:32:372026-10-13 11:32:37Hansa Biopharma to participate in Virtual US Bancorp / BTIG Kidney Health Forum
https://www.optimumcomms.com/wp-content/uploads/2026/10/event-guide-pr-thumbnail.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-13 08:31:362026-10-13 08:31:36Optimum Strategic Communications and Catalyst Advisors launch the official Networking Event Guide around the Jefferies Global Healthcare Conference
https://www.optimumcomms.com/wp-content/uploads/2026/10/ionctura-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-09 10:32:492026-10-09 11:06:47A promising new chapter for PI3Kδ inhibition: Nature Communications publications reveal novel mechanism behind iOnctura’s roginolisib
https://www.optimumcomms.com/wp-content/uploads/2026/06/BioEurope_Logo_300x180px-80x80Web_Logos-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-07 08:41:262026-10-07 10:44:02BIO-Europe C-Suite Survey: Biopharma dealmaking set to accelerate, but investor caution still caps ambition
https://www.optimumcomms.com/wp-content/uploads/2024/05/Template_Logo_300x180px-80x80Web_Logos-1.jpg
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-06 08:43:502026-10-06 08:43:50Resolution Therapeutics to present interim Phase I/II EMERALD study data on RTX001 as a late-breaker at AASLD 2026
https://www.optimumcomms.com/wp-content/uploads/2026/10/rouge-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-06 08:38:382026-10-06 08:38:38RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-06 08:32:472026-10-06 10:51:42Optimum Strategic Communications to Host 18th Annual Healthcare Investor Conference
https://www.optimumcomms.com/wp-content/uploads/2023/12/Poolbeg_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-06 08:32:082026-10-06 08:32:08Poolbeg Pharma – Cancer Immunotherapy-Induced CRS Patent Granted in South Korea
https://www.optimumcomms.com/wp-content/uploads/2025/06/Rewind_Logo_300x180px-80x80Web_Logos.jpg
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-06 08:00:422026-10-06 08:00:42Rewind Therapeutics Secures Additional Financing to Advance Oral GPR17 Remyelination Program
https://www.optimumcomms.com/wp-content/uploads/2024/11/Freya_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-05 14:37:452026-10-05 14:37:45Freya Biosciences named as one of Fierce Biotech’s “Fierce 15” for 2026
https://www.optimumcomms.com/wp-content/uploads/2025/09/Hansa-Biopharma.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-02 10:40:212026-10-02 10:40:21Hansa Biopharma to participate in 26th Annual Biotech in Europe Forum
https://www.optimumcomms.com/wp-content/uploads/2023/02/ViCentra_Logo_300x180px-3.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-01 12:55:062026-10-01 12:55:06ViCentra Presents Large-Scale Real-World Evidence Demonstrating Kaleido Insulin Patch Pump System Delivers Stable Glucose Control with Very Low Hypoglycemia
https://www.optimumcomms.com/wp-content/uploads/2025/09/Hansa-Biopharma.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-01 09:48:492026-10-01 09:48:49Hansa Biopharma Partners with Cradle to Advance AI-Driven Protein Design and Engineering
https://www.optimumcomms.com/wp-content/uploads/2025/09/DaltonTx.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-01 08:32:122026-10-01 08:32:12DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform
https://www.optimumcomms.com/wp-content/uploads/2026/09/numab-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-01 08:31:312026-10-01 08:31:31Numab Therapeutics Appoints Dr. Rajesh Chopra as Chief Scientific Officer to Advance its Proprietary Multispecific Antibody Pipeline
https://www.optimumcomms.com/wp-content/uploads/2025/06/Atrogi_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-01 08:31:222026-10-01 08:31:22Atrogi announces positive human data for ATR-258, its first-in-class, oral therapy designed to improve muscle function and body compositionFor more information about Optimum Strategic Communications, please get in touch.
